I assume that you're only joking, but seriously I don't think MOGN invested that money for SUPG's stock to appreciate as much as they did to close the dacogen deal. Future Dacogen revenues will more than compensate them for any small loss in SUPG equity. As CVA had stated, it was merely window dressing to help demonstrate to shareholders that the stock was worth more than the $6 range. It says nothing, however, about what the stock price should be.
I agree with what your saying. A good biotech partnership for a late stage drug would go something like this, MOGN pays upfront fee of 50 million plus takes an equity stake for another 30 million. Milestones include 10 million for filing of NDA, plus another 50 million upon FDA approval and pays for all other clinical trials. The key being that SUPG would build a salesforce of say 40 reps and split Dacogen revenue 50/50. Maybe get 10 percent royalty on EU and ROW sales. Thats what SUPG shareholders wanted, they didn't get it and thats why smart money is moving on.
Duragen your an ass. Get off the board. Goddamn all ya have to do is read the Fuckin news. MOGN is gonna make big bucks off Dacegon Drug. SUPG willmake money off the royalty rights. But goofs like you think your gonna scare people into selling or just upset them off a message board. Ya know what I made nice money off WMGI today and my hold on SUPG is just that. A long term hold. Post on this board in a year and we will see who was right about SUPG.
I've disclosed that I'm shortselling SUPG, and I'm just posting my opinion why I think the stock is selling off and why I think the Dacogen deal is weak. You can either respond and refute me or blab like alittle baby. I understand your losing money and your frustrated and I'm not trying rub salt in your wounds. But I will be here tomorrow continuing my sermon.